<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EB807275-D239-41F7-9C97-05ADC965F4E7"><gtr:id>EB807275-D239-41F7-9C97-05ADC965F4E7</gtr:id><gtr:name>Spanish National Centre for Biotechnology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/94B27935-7715-4A44-8E8E-D28A015DE6AB"><gtr:id>94B27935-7715-4A44-8E8E-D28A015DE6AB</gtr:id><gtr:name>Upstate Biotechnology, Inc.</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BA1262B0-0B41-45FA-A328-24E788FF4D34"><gtr:id>BA1262B0-0B41-45FA-A328-24E788FF4D34</gtr:id><gtr:name>CYTOO</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FC01E59D-8131-4D32-821C-FDCE24B7B03E"><gtr:id>FC01E59D-8131-4D32-821C-FDCE24B7B03E</gtr:id><gtr:name>University Hospital Zurich</gtr:name><gtr:address><gtr:line1>UniversitatsSpital Zurich</gtr:line1><gtr:postCode>CH-8091</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D24E60EE-4C36-4709-BD06-8A0F979DF2E8"><gtr:id>D24E60EE-4C36-4709-BD06-8A0F979DF2E8</gtr:id><gtr:name>Sigma-Aldrich</gtr:name><gtr:address><gtr:line1>3050 Spruce Street</gtr:line1><gtr:postCode>MO 63103</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68FB3A84-29CE-4F10-B27B-1482AD81759C"><gtr:id>68FB3A84-29CE-4F10-B27B-1482AD81759C</gtr:id><gtr:name>Beatson Institute for Cancer Research</gtr:name><gtr:department>Research Group Y35 (Karen Blyth)</gtr:department><gtr:address><gtr:line1>Garscube Estate</gtr:line1><gtr:line2>Switchback Road, Bearsden</gtr:line2><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G61 1BD</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68FB3A84-29CE-4F10-B27B-1482AD81759C"><gtr:id>68FB3A84-29CE-4F10-B27B-1482AD81759C</gtr:id><gtr:name>Beatson Institute for Cancer Research</gtr:name><gtr:address><gtr:line1>Garscube Estate</gtr:line1><gtr:line2>Switchback Road, Bearsden</gtr:line2><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G61 1BD</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EB807275-D239-41F7-9C97-05ADC965F4E7"><gtr:id>EB807275-D239-41F7-9C97-05ADC965F4E7</gtr:id><gtr:name>Spanish National Centre for Biotechnology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/94B27935-7715-4A44-8E8E-D28A015DE6AB"><gtr:id>94B27935-7715-4A44-8E8E-D28A015DE6AB</gtr:id><gtr:name>Upstate Biotechnology, Inc.</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BA1262B0-0B41-45FA-A328-24E788FF4D34"><gtr:id>BA1262B0-0B41-45FA-A328-24E788FF4D34</gtr:id><gtr:name>CYTOO</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC01E59D-8131-4D32-821C-FDCE24B7B03E"><gtr:id>FC01E59D-8131-4D32-821C-FDCE24B7B03E</gtr:id><gtr:name>University Hospital Zurich</gtr:name><gtr:address><gtr:line1>UniversitatsSpital Zurich</gtr:line1><gtr:postCode>CH-8091</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D24E60EE-4C36-4709-BD06-8A0F979DF2E8"><gtr:id>D24E60EE-4C36-4709-BD06-8A0F979DF2E8</gtr:id><gtr:name>Sigma-Aldrich</gtr:name><gtr:address><gtr:line1>3050 Spruce Street</gtr:line1><gtr:postCode>MO 63103</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7FF42134-6418-4FF7-8C47-9473D63D8D1C"><gtr:id>7FF42134-6418-4FF7-8C47-9473D63D8D1C</gtr:id><gtr:firstName>Laura</gtr:firstName><gtr:surname>Machesky</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G117%2F569"><gtr:id>1B8E551B-1A74-4C92-883F-8506FB9D2094</gtr:id><gtr:title>Actin assembly in filopodia and lamellipodia: Regulation of the Arp2/3 Complex by Scar and IRSp53</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G117/569</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>We aim to determine how actin assembly is regulated in response to activation of various receptors, including during cell spreading. In particular, we want to know how the actin nucleating complex, Arp2/3, is controlled by Scar proteins and by IRSp53 to regulate the balance between filopodia and lamellipodia assembly in platelets and fibroblasts. We have four main aims. Firstly, we have recently discovered that Scar1 null mice have abnormal platelets that do not spread properly on extracellular matrix. Thus, Scar1 appears to be an essential controller of actin dynamics in response to integrin engagement in platelets. We aim to fully characterise the role of Scar1 in platelets. Secondly, we have also found abnormalities in Scar1 null fibroblasts that are distinct from those previously reported by another group. We will determine the role of Scar1 in fibroblast spreading and responses to growth factors using a combination of imaging and biochemical methods. Thirdly, we will also investigate connections between Scars and the exocytic machinery, specifically, the interaction between Scar2 and Sec3. Fourthly, we have solved the crystal structure of a key actin bundling protein and ligand of Scar1, IRSp53 IMD. We will determine how IRSp53 connects to Scar proteins as a mediator of filopod assembly using biophysical and cell biological methods. Our studies are relevant to haemostatic diseases, cancer, inflammation, neurological diseases and wounding. Arp2/3 complex subunits have been implicated in gastric cancers (Kaneda, 2002 #229); Scar proteins may be targets for congenital neurological diseases and cell migration/motility are essential to all of these processes (Kitamura 2003a, 2003b).</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1510281</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>CYTOO</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Use of patterned substrates for the study of cell polarity</gtr:description><gtr:id>2D32C4AE-FCAE-440E-903C-2D3129F53142</gtr:id><gtr:impact>We were given free samples of materials from CYTOO to study cell polarity on micro-patterned cell matrix coverslips. We will be a beta test site for these materials. This will allow us access to these state-of-the art materials which may be very valuable for our research.</gtr:impact><gtr:outcomeId>73D99D2FEA3-1</gtr:outcomeId><gtr:partnerContribution>We will be given free samples of materials from CYTOO to study cell polarity on micro-patterned cell matrix coverslips. We will be a beta test site for these materials. This will allow us access to these state-of-the art materials which may be very valuable for our research.</gtr:partnerContribution><gtr:piContribution>We will be given free samples of materials from CYTOO to study cell polarity on micro-patterned cell matrix coverslips. We will be a beta test site for these materials. This will allow us access to these state-of-the art materials which may be very valuable for our research.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sigma-Aldrich</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Development of antibodies to Arp2 and Arp3</gtr:description><gtr:id>79C06FFA-97D9-4D89-8418-566700640BFF</gtr:id><gtr:impact>We developed antibodies to Arp2 and Arp3 subunits of the Arp2/3 complex with Sigma Israel. This collaboration has led to two very useful reagents that are now available both to our group and to the wider research community.</gtr:impact><gtr:outcomeId>1BC73CB579B-1</gtr:outcomeId><gtr:partnerContribution>These antibodies are made available to our group free of charge</gtr:partnerContribution><gtr:piContribution>We developed the antigen expression in E coli and we tested the antiserum for the company</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Technology (MRCT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Drug discovery: fascin and metastasis</gtr:description><gtr:id>83F97476-F379-42B2-9F44-EC0FE29FF1D8</gtr:id><gtr:impact>This collaboration has been very central to my research programme on invasion and metastasis. It is multidisciplinary and involves chemistry, biophysical studies (X-ray crystallography and NMR), cell biology and mouse genetic studies.</gtr:impact><gtr:outcomeId>NfTPPERhxSs-1</gtr:outcomeId><gtr:partnerContribution>We have set up a programme between Beatson Drug Discovery, my group and MRC-T to screen for new inhibitors of fascin-1, a protein implicated in migration and metastasis in epithelial cancers. Each group has contributed experimental work, reagents and intellectually to this collaboration.</gtr:partnerContribution><gtr:piContribution>WE have set up in vitro and in vivo models to study fascin function in invasion and migration as well as cancer metastasis. We have set up and performed assays on candidate compounds. We have provided expertise and DNA/protein reagents as well as cells to both Beatson Drug Discovery and MRC-T.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Spanish National Centre for Biotechnology</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Collaboration with Ines Anton, CNB Madrid</gtr:description><gtr:id>5C35039E-5288-4492-89E5-B68842AEC62A</gtr:id><gtr:impact>We have had 3 publications so far and a 4th has just been accepted in the Journal of Cell Science</gtr:impact><gtr:outcomeId>545dfca219bb46.53003308-1</gtr:outcomeId><gtr:partnerContribution>Ines and Esther provided expertise to study WIP and in the study of breast cancer cells.</gtr:partnerContribution><gtr:piContribution>A student from Ines lab, Esther Garcia, came to our group for several months on an EMBO fellowshipvand a fellowship from the CNB in Spain to study the role of WIP in cell migration and invasion in breast cancer cells. This has led to several publications involving Ines Anton and Esther Garcia. Our group trained Esther in doing cell invasion assays and measuring migration quantitatively.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital Zurich</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Collaboration with Ruoss and Bender</gtr:description><gtr:id>52625149-7E0D-4E73-81F1-358A8B86E4EF</gtr:id><gtr:impact>No outputs yet.</gtr:impact><gtr:outcomeId>56d5a3e75ec8a9.13436433-1</gtr:outcomeId><gtr:partnerContribution>Our partners will perform research to determine the effect of deletion of cytoskeletal genes (CYFIP1 and Strumpellin) on platelet and megakaryocyte development and function. They will perform most of the wet lab work and we will provide expertise and reagents as needed.</gtr:partnerContribution><gtr:piContribution>We will provide knockout mice for cytoskeletal genes that this group will study to determine whether the platelets are affected. My work with the BHF funded projects on platelets was hugely important to my being a part of this new collaboration with the hospital lab in Wuerzburg. I am the co-supervisor of the PhD student who is doing this project, so I will provide supervision and expertise throughout her PhD.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Upstate Biotechnology, Inc.</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Development of antibodies to p34-Arc</gtr:description><gtr:id>9669F124-8CE6-46A9-8A8D-D4FBCD452D92</gtr:id><gtr:impact>We have developed a polyclonal antibody that is now sold by Upstate Biotech (Millipore). This is extremely useful to us, as it also ensures a long-term supply of a valuable reagent to our group.</gtr:impact><gtr:outcomeId>F9BF26DC9EC-1</gtr:outcomeId><gtr:partnerContribution>It has maintained a supply of excellent antibody that we can use free of charge for our work.</gtr:partnerContribution><gtr:piContribution>We developed an antibody against p34-Arc of the Arp2/3 complex and tested antiserum for the company.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>CRUK Relay for life</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>AF326274-6E5B-42FF-9AD9-1F6F12CBF083</gtr:id><gtr:impact>I gave a talk to cancer survivors and to all interested members of the public - e.g. families and supporters- about basic scientific research on cell migration and its importance for medical research and disease studies.

I have volunteered to do this activity every year. I don't think you can measure the impact, but I hope that it is obvious that communicating to the public about cell motility research and how it is important for medical issues such as cancer will have an impact on society.</gtr:impact><gtr:outcomeId>6F104E86A51</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit to Undergraduate College Alma, MI, USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1A021762-47B7-44FC-82E8-393B9E71E4FF</gtr:id><gtr:impact>100 undergraduates and several faculty at this undergraduate college in Michigan attended my seminar about cancer metastasis and cell migration. We also held a careers workshop, which was attended by more than 100 first year undergraduates. My talks hopefully inspired these students to consider a career in scientific research.

We will set up an internship for an Alma College student to visit my laboratory here in Glasgow in the summer and receive training and experience in cell biology and cancer research.</gtr:impact><gtr:outcomeId>EeDapojj9wZ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting with CRUK charity workers</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A9AE31CF-B987-4577-9442-49365A01BFE8</gtr:id><gtr:impact>10 volunteers attended a talk and tour of the institute and we had a coffee time for discussion and questions

We received positive feedback form the volunteers about the day</gtr:impact><gtr:outcomeId>RvLv7Kw9ZBM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Institute Programme Beatson Institute</gtr:description><gtr:end>2012-11-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>BD235EF0-7D1E-4891-A8D1-8C319A86DA01</gtr:id><gtr:outcomeId>ACD0CB54E770</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AICR Project Grant</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>Association for International Cancer Research (AICR)</gtr:fundingOrg><gtr:fundingRef>110-119</gtr:fundingRef><gtr:id>08966166-4E53-463E-9103-79F11A500402</gtr:id><gtr:outcomeId>3034AD4961F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>170000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AICR project grant</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Association for International Cancer Research (AICR)</gtr:fundingOrg><gtr:id>95FB59DE-2EFE-4409-912B-9D2FAD35FF63</gtr:id><gtr:outcomeId>ZgcUdvCX4D90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Institute Programme Beatson Institute</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>15673</gtr:fundingRef><gtr:id>0EE58F95-FCC5-4002-9E26-7820F367D87B</gtr:id><gtr:outcomeId>ACD0CB54E771</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Project Grant</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>FS/09/034/27756</gtr:fundingRef><gtr:id>E9B12350-50DD-4B91-BB1D-030660F71713</gtr:id><gtr:outcomeId>B651A37F5580</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have created several useful antibody reagents that are now commercially available- please see &amp;quot;collaborations section&amp;quot;</gtr:description><gtr:id>5F123130-B072-47A5-8F0C-00506B674550</gtr:id><gtr:impact>This material has helped many groups achieve primary research goals, such as publications and new knowledge about the actin cytoskeleton and cell motility.</gtr:impact><gtr:outcomeId>AF1832FAD70</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Antibodies</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed hundreds of DNA expression plasmids for research use. We routinely make these available to other researchers upon request. We receive around 50 requests per year for our plasmids.</gtr:description><gtr:id>374E3111-A418-426B-BBA6-35267812F56D</gtr:id><gtr:impact>Many scientific publications and discoveries have arisen from use of our DNA reagents. We have also developed numerous collaborations with other groups around the world.</gtr:impact><gtr:outcomeId>U1RYaEzVcUB</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>DNA expression plasmids</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6E2CE6FE-5798-437F-A924-331BDA8B7231</gtr:id><gtr:title>Involvement of Rac in actin cytoskeleton rearrangements induced by MIM-B.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b906a9d6bc70b12da7a9df1e28838f4"><gtr:id>8b906a9d6bc70b12da7a9df1e28838f4</gtr:id><gtr:otherNames>Bompard G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>E1F0ECC5235</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F2BD1D8-E382-4582-999C-85B5DEEC09A2</gtr:id><gtr:title>A major role for Scar/WAVE-1 downstream of GPVI in platelets.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b54461412782f462ecfb14aedc7e8c5"><gtr:id>5b54461412782f462ecfb14aedc7e8c5</gtr:id><gtr:otherNames>Calaminus SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>0BC0D3CA643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2754E9E9-6766-421A-8AED-475972C98124</gtr:id><gtr:title>A complex between FAK, RACK1, and PDE4D5 controls spreading initiation and cancer cell polarity.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3ee6a846d9c19caa20dd8a1b043a0f8"><gtr:id>b3ee6a846d9c19caa20dd8a1b043a0f8</gtr:id><gtr:otherNames>Serrels B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>pdjfW1kfvhS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13FFDBFB-ADAE-4196-814D-C256A7A05AAF</gtr:id><gtr:title>Mtss1 regulates epidermal growth factor signaling in head and neck squamous carcinoma cells.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b6a6b12e39eef1a4b5db4a9e4909276"><gtr:id>7b6a6b12e39eef1a4b5db4a9e4909276</gtr:id><gtr:otherNames>Dawson JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>oiXdmCHWkrG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D95FF84-4035-4A20-8683-653B13C93FBA</gtr:id><gtr:title>Identification of a novel, actin-rich structure, the actin nodule, in the early stages of platelet spreading.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b54461412782f462ecfb14aedc7e8c5"><gtr:id>5b54461412782f462ecfb14aedc7e8c5</gtr:id><gtr:otherNames>Calaminus SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>A6F5389F534</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E16080B6-6C5F-4C5B-9D0A-B9BE337CC536</gtr:id><gtr:title>The actin binding proteins cortactin and HS1 are dispensable for platelet actin nodule and megakaryocyte podosome formation.</gtr:title><gtr:parentPublicationTitle>Platelets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e5b72eedb2c85b40bf0e1d59e27c0e9"><gtr:id>7e5b72eedb2c85b40bf0e1d59e27c0e9</gtr:id><gtr:otherNames>Thomas SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0953-7104</gtr:issn><gtr:outcomeId>58b59bf708b842.92172967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC9DDB9B-5707-4F6C-9928-581D3FDC479D</gtr:id><gtr:title>Rac1 is essential for platelet lamellipodia formation and aggregate stability under flow.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7edd426b5a61967abc9c0179a1fd40a9"><gtr:id>7edd426b5a61967abc9c0179a1fd40a9</gtr:id><gtr:otherNames>McCarty OJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>99CDCC229D7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09F4BEE1-BD20-4938-A279-4EEB233FDF49</gtr:id><gtr:title>MIM: a multifunctional scaffold protein.</gtr:title><gtr:parentPublicationTitle>Journal of molecular medicine (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36d791bfc051e5861fea041dcebc96d9"><gtr:id>36d791bfc051e5861fea041dcebc96d9</gtr:id><gtr:otherNames>Machesky LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0946-2716</gtr:issn><gtr:outcomeId>7C615D6BC4D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>283C78AA-1282-4206-9CE6-41831583A5F0</gtr:id><gtr:title>Myopathy-causing actin mutations promote defects in serum-response factor signalling.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44e2bdba90a6d9431cc30d2f58a8bfa7"><gtr:id>44e2bdba90a6d9431cc30d2f58a8bfa7</gtr:id><gtr:otherNames>Visegr?dy B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>TeC7JkbvpqD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6645F8B-3784-4EC9-9259-F11BDB557ED0</gtr:id><gtr:title>Actin dynamics at the leading edge: from simple machinery to complex networks.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dcd3ea59c0de1de483d550e27658de4"><gtr:id>0dcd3ea59c0de1de483d550e27658de4</gtr:id><gtr:otherNames>Insall RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>54B6D3B766F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F1AA05C-4471-4F3C-B5B8-76C8676E9DC0</gtr:id><gtr:title>Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db32bf3795a7ac1ca70fee36af4e8574"><gtr:id>db32bf3795a7ac1ca70fee36af4e8574</gtr:id><gtr:otherNames>Stein T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>hQzHHGErfuo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45A1914F-A14F-40C8-A8AA-47A63127362B</gtr:id><gtr:title>Rac1 drives melanoblast organization during mouse development by orchestrating pseudopod- driven motility and cell-cycle progression.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c5c2253c4ba1d1ab5829aa152019a46"><gtr:id>7c5c2253c4ba1d1ab5829aa152019a46</gtr:id><gtr:otherNames>Li A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>e9D2PRPwweW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BE02A90-A868-42F9-A17B-4C2D80141C58</gtr:id><gtr:title>The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c5c2253c4ba1d1ab5829aa152019a46"><gtr:id>7c5c2253c4ba1d1ab5829aa152019a46</gtr:id><gtr:otherNames>Li A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>iWrgpHBxPup</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02B4B1DB-F9ED-425D-8DBC-FBAD1676C4BA</gtr:id><gtr:title>Mtss1 promotes cell-cell junction assembly and stability through the small GTPase Rac1.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b6a6b12e39eef1a4b5db4a9e4909276"><gtr:id>7b6a6b12e39eef1a4b5db4a9e4909276</gtr:id><gtr:otherNames>Dawson JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13253_23_22479308</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0166B88-F8B0-4E63-8CE9-D87C01AB2E06</gtr:id><gtr:title>N-WASP involvement in dorsal ruffle formation in mouse embryonic fibroblasts.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c19783aa227502f5b0c0226892015a0"><gtr:id>3c19783aa227502f5b0c0226892015a0</gtr:id><gtr:otherNames>Legg JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn><gtr:outcomeId>39D2B3F032C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>907359DF-3347-4F29-8CAD-71523DFAB6E7</gtr:id><gtr:title>MyosinIIa contractility is required for maintenance of platelet structure during spreading on collagen and contributes to thrombus stability.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b54461412782f462ecfb14aedc7e8c5"><gtr:id>5b54461412782f462ecfb14aedc7e8c5</gtr:id><gtr:otherNames>Calaminus SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>F53E87A89CB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47C97F78-D4BA-4206-BA53-8EB4F8FFE3BD</gtr:id><gtr:title>Arp2/3 complex activity in filopodia of spreading cells.</gtr:title><gtr:parentPublicationTitle>BMC cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dd8c9d9600f2ef429868b82ca5e1e50"><gtr:id>6dd8c9d9600f2ef429868b82ca5e1e50</gtr:id><gtr:otherNames>Johnston SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-2121</gtr:issn><gtr:outcomeId>86BC5E48FAD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE5C61E0-29D4-4202-8DB5-994AEDB44DD5</gtr:id><gtr:title>Rab5 and rac team up in cell motility.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/665afe8ff251ea520878570f875d363e"><gtr:id>665afe8ff251ea520878570f875d363e</gtr:id><gtr:otherNames>Zech T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>00523B6BB7A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73A1DDE8-B1D7-4301-AA7B-14C16CBF7B81</gtr:id><gtr:title>Lamellipodia and filopodia in metastasis and invasion.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36d791bfc051e5861fea041dcebc96d9"><gtr:id>36d791bfc051e5861fea041dcebc96d9</gtr:id><gtr:otherNames>Machesky LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>C608F6DD040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFAC4B1F-D33B-428E-8664-724B044DD190</gtr:id><gtr:title>WAVE/Scars in platelets.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91d609d93bb72e655bc07973eeec02ff"><gtr:id>91d609d93bb72e655bc07973eeec02ff</gtr:id><gtr:otherNames>Oda A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>2BAE11C085E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAA82678-C4D7-4AF3-B93B-B1266F544DE6</gtr:id><gtr:title>Phenotypes induced by NM causing alpha-skeletal muscle actin mutants in fibroblasts, Sol 8 myoblasts and myotubes.</gtr:title><gtr:parentPublicationTitle>BMC research notes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b436b5b5c8c9f9001ae1d59c6680e2ec"><gtr:id>b436b5b5c8c9f9001ae1d59c6680e2ec</gtr:id><gtr:otherNames>Vandamme D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1756-0500</gtr:issn><gtr:outcomeId>46922F94B70</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64DD0CFC-C0A9-4722-AB7D-CC73C2BB8503</gtr:id><gtr:title>G-protein coupled and ITAM receptor regulation of the formin FHOD1 through Rho kinase in platelets.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e5b72eedb2c85b40bf0e1d59e27c0e9"><gtr:id>7e5b72eedb2c85b40bf0e1d59e27c0e9</gtr:id><gtr:otherNames>Thomas SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>cox9HV8tjTV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9412F26-4631-476B-B4D5-CCF1ECFE92DB</gtr:id><gtr:title>The Nance-Horan syndrome protein encodes a functional WAVE homology domain (WHD) and is important for co-ordinating actin remodelling and maintaining cell morphology.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5642ebb664dd6c35df24e96dd22be6d"><gtr:id>b5642ebb664dd6c35df24e96dd22be6d</gtr:id><gtr:otherNames>Brooks SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>mV3X5kncwY8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F8B2962-9A45-4769-8437-0124F21F62E3</gtr:id><gtr:title>Cells assemble invadopodia-like structures and invade into matrigel in a matrix metalloprotease dependent manner in the circular invasion assay.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1879cf77e5158dd3c9b1fb0724cc2274"><gtr:id>1879cf77e5158dd3c9b1fb0724cc2274</gtr:id><gtr:otherNames>Yu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13253_23_22347388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>104FBE3F-4CF2-4760-A607-6CF54D54FF4B</gtr:id><gtr:title>Fascin: Invasive filopodia promoting metastasis.</gtr:title><gtr:parentPublicationTitle>Communicative &amp; integrative biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36d791bfc051e5861fea041dcebc96d9"><gtr:id>36d791bfc051e5861fea041dcebc96d9</gtr:id><gtr:otherNames>Machesky LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1942-0889</gtr:issn><gtr:outcomeId>h8seEAkNQw6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3843764-77DD-46D1-BD1E-A5BD320ECD48</gtr:id><gtr:title>Functional analysis of Dictyostelium IBARa reveals a conserved role of the I-BAR domain in endocytosis.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fbf74e6d4ce2c856e1f412c1c0d1d69"><gtr:id>4fbf74e6d4ce2c856e1f412c1c0d1d69</gtr:id><gtr:otherNames>Veltman DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_13253_23_21401524</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BB4CB1C-DC00-4BCA-9B59-2426F03154AD</gtr:id><gtr:title>N-WASP coordinates the delivery and F-actin-mediated capture of MT1-MMP at invasive pseudopods.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1879cf77e5158dd3c9b1fb0724cc2274"><gtr:id>1879cf77e5158dd3c9b1fb0724cc2274</gtr:id><gtr:otherNames>Yu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>pm_13253_23_23091069</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83B8F863-F0A1-4F96-A9FE-750C11EA94C7</gtr:id><gtr:title>The Arp2/3 activator WASH regulates a5?1-integrin-mediated invasive migration.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/665afe8ff251ea520878570f875d363e"><gtr:id>665afe8ff251ea520878570f875d363e</gtr:id><gtr:otherNames>Zech T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>doi_55f985985bd7be94</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBEC4C41-2A50-45DE-81E4-1BE4AE37E0D5</gtr:id><gtr:title>Actin-based protrusions: promoters or inhibitors of cancer invasion?</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36d791bfc051e5861fea041dcebc96d9"><gtr:id>36d791bfc051e5861fea041dcebc96d9</gtr:id><gtr:otherNames>Machesky LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>1EB428ADCB5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E41D843-B68E-47B0-AA6C-8C390289586F</gtr:id><gtr:title>LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3175e6bfaa9fb50fec4c8b0bae3a669"><gtr:id>e3175e6bfaa9fb50fec4c8b0bae3a669</gtr:id><gtr:otherNames>Scott RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>k4txYsxcSMm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C30218D3-164D-4A73-A912-E3826AFC643A</gtr:id><gtr:title>Grab, stick, pull and digest: the functional diversity of actin-associated matrix-adhesion structures. Workshop on Invadopodia, Podosomes and Focal Adhesions in Tissue Invasion.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8493028042ac1014bb1548d78760fe19"><gtr:id>8493028042ac1014bb1548d78760fe19</gtr:id><gtr:otherNames>Machesky L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>CFDCA53826E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F75258E-5AB2-44DC-B9E8-13F7F9096054</gtr:id><gtr:title>Actin polymerization driven by WASH causes V-ATPase retrieval and vesicle neutralization before exocytosis.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/977f8cbcf520eb528d32f24f04124ba1"><gtr:id>977f8cbcf520eb528d32f24f04124ba1</gtr:id><gtr:otherNames>Carnell M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>EqiUvPjhMdz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A2601EB-19AE-4D57-A27B-A3B4CD02999B</gtr:id><gtr:title>WIP and WICH/WIRE co-ordinately control invadopodium formation and maturation in human breast cancer cell invasion.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/028936f59eb9fc9434f061c8aff491fe"><gtr:id>028936f59eb9fc9434f061c8aff491fe</gtr:id><gtr:otherNames>Garc?a E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58b59bf79d70a2.37049632</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFC57579-6978-435C-B332-E794437C0D1C</gtr:id><gtr:title>Spred2 interaction with the late endosomal protein NBR1 down-regulates fibroblast growth factor receptor signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e43d948d721d01de66b8bd2cf1bd45f"><gtr:id>8e43d948d721d01de66b8bd2cf1bd45f</gtr:id><gtr:otherNames>Mardakheh FK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>FEC2070B52F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A731BCAD-D5F6-4723-9B75-27E13ABA2866</gtr:id><gtr:title>Bacterial and host determinants of MAL activation upon EPEC infection: the roles of Tir, ABRA, and FLRT3.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3bd21f0feb075abef649fb6a8c35290"><gtr:id>e3bd21f0feb075abef649fb6a8c35290</gtr:id><gtr:otherNames>Heath RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>Nhq6H2Yf7Cg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3EB4E03-0F09-46B9-89F4-6E9978B427DA</gtr:id><gtr:title>&amp;quot;Wunder&amp;quot; F-BAR domains: going from pits to vesicles.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e201911cd1b3c5ed873d0157c2ee414"><gtr:id>2e201911cd1b3c5ed873d0157c2ee414</gtr:id><gtr:otherNames>F?tterer K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>9654945B583</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>528B6D63-D74B-4F76-8087-8E785B6BBF03</gtr:id><gtr:title>Characterisation of IRTKS, a novel IRSp53/MIM family actin regulator with distinct filament bundling properties.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec86ebdf424f37cd72d4bad039c1b4fe"><gtr:id>ec86ebdf424f37cd72d4bad039c1b4fe</gtr:id><gtr:otherNames>Millard TH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>E604C9CA113</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A513E187-62E4-43A1-B171-1CDF4C469F6B</gtr:id><gtr:title>Identification of the insulin-responsive tyrosine phosphorylation sites on IRSp53.</gtr:title><gtr:parentPublicationTitle>European journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ae0649c1808a446800e23157b3b4a41"><gtr:id>8ae0649c1808a446800e23157b3b4a41</gtr:id><gtr:otherNames>Heung MY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0171-9335</gtr:issn><gtr:outcomeId>CB360790835</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E3E66FB-0D45-4A31-B009-BB46D9D1675B</gtr:id><gtr:title>The role of Arabidopsis SCAR genes in ARP2-ARP3-dependent cell morphogenesis.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff589fb3e197276606f7a15144ed9311"><gtr:id>ff589fb3e197276606f7a15144ed9311</gtr:id><gtr:otherNames>Uhrig JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>E88016290A0</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G117/569</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>